7 results
10-K
2023 FY
TSBX
Turnstone Biologics Corp
21 Mar 24
Annual report
8:51pm
that are utilizing bulk TILs, including newer bulk TIL approaches that introduce genetic modifications and culture media additives to enhance TIL quality and function … we are evaluating enhanced culture conditions during the TIL production process to maintain and further improve TIL quality ex vivo. These enhanced
8-K
EX-99.1
TSBX
Turnstone Biologics Corp
5 Mar 24
Regulation FD Disclosure
8:30am
fragments were placed into separate multi-well tissue culture dishes and cultured with the tumor or manufactured antigens. TIL populations that were activated … by exposure to tumor antigens in culture would then be identified based on cytokine expression and/or T cell activation marker expression, and only
424B4
TSBX
Turnstone Biologics Corp
21 Jul 23
Prospectus supplement with pricing info
7:14pm
and culture media additives to enhance TIL quality and function (meaning the viability of the TILs and their ability to produce cytotoxic and immune … pipeline programs where we are evaluating enhanced culture conditions during the TIL production process to maintain and further improve TIL quality ex vivo
S-1/A
TSBX
Turnstone Biologics Corp
23 Jun 23
IPO registration (amended)
9:49pm
and culture media additives to enhance TIL quality and function (meaning the viability of the TILs and their ability to produce cytotoxic and immune activating … programs where we are evaluating enhanced culture conditions during the TIL production process to maintain and further improve TIL quality ex vivo
S-1
nsbvwwh3x nz7
12 Jun 23
IPO registration
4:28pm
DRS
3ia4l
15 May 23
Draft registration statement
12:00am
- Prev
- 1
- Next